Codexis finally finds CFO
This article was originally published in Scrip
Codexis, a developer of industrial enzymes used to make sophisticated pharmaceutical intermediates, has finally found a replacement CFO for Robert Lawson who left the company in January. David O'Toole takes up the role of vice-president and CFO having most recently served as vice-president and CFO at Response Genetics. He has 12 years' experience in the life science and biotech industries.